Chlamydia clinical trials at UCLA
1 in progress, 0 open to eligible people
Showing trials for
Doxycycline Prophylaxis for Prevention of Sexually Transmitted Infections
Sorry, not currently recruiting here
The goal of this open-label, randomized trial is to assess the efficacy of doxycycline prophylaxis in reducing incidences of bacterial sexually transmitted infections (STIs) among adolescent and young adult females while also evaluating acceptability and antimicrobial resistance in order to inform public health policy.
Los Angeles, California and other locations
Our lead scientists for Chlamydia research studies include Cherie Blaire, MD, PhD.
Last updated: